Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Geron rises on 2Q results and imetelstat update
Yahoo/AP
Saturday, August 10, 2013 - 12:08pm
tags:
Geron, earnings, imetelstat, myelofibrosis
Ariad: Succumbing Temporarily To Extraordinary Pressure
Seeking Alpha
Saturday, August 10, 2013 - 12:07pm
tags:
Ariad
Codexis Reports Second Quarter 2013 Results
Yahoo/BusinessWire
Saturday, August 10, 2013 - 12:06pm
tags:
Codexis, earnings
BioTime Announces Second Quarter 2013 Financial Results and Recent Corporate Accomplishments
Yahoo/BusinessWire
Saturday, August 10, 2013 - 12:06pm
tags:
BioTime, earnings
Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
Seeking Alpha
Friday, August 9, 2013 - 4:57pm
tags:
earnings, Regeneron, Eylea, Amgen, Novartis, Pfizer, Sanofi
Sucampo CEO search an unexpected positive, says Cantor
Yahoo/Fly on the Wall
Friday, August 9, 2013 - 1:16pm
tags:
Sucampo
Allergan takes latest IP hit as India revokes 2 patents
Fierce Biotech
Friday, August 9, 2013 - 1:11pm
tags:
Allergan, India, patents, Ganfort, Combigan
Dendreon retreats after earnings miss, Provenge warning
The Fly on the Wall
Friday, August 9, 2013 - 1:05pm
tags:
Dendreon, earnings, Provenge
Salix Pharma Stock Falls On Earnings, Guidance Miss
Investors.com
Friday, August 9, 2013 - 1:04pm
tags:
earnings, Salix
Arena's Week 8 Sales Modestly Up
Seeking Alpha
Friday, August 9, 2013 - 12:17pm
tags:
Arena Pharmaceuticals, Belviq, Eisai
Vivus' Qsymia Sales Take A Dip
Seeking Alpha
Friday, August 9, 2013 - 12:16pm
tags:
Vivus, obesity, Qsymia
BioDelivery Sciences on track to report data from two Phase 3 studies in 2014
Yahoo/Fly on the Wall
Friday, August 9, 2013 - 10:44am
tags:
BioDelivery Sciences, Bunavail, opioid addiction
Should You Keep an Eye on These Eye Treatment Biotechs?
Motley Fool
Friday, August 9, 2013 - 10:30am
tags:
wet age-related macular degeneration, diabetic macular edema, Lucentis, Novartis, Roche, Eylea, Regeneron, Optina, Ampio Pharmaceuticals
Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug
Fierce Biotech
Friday, August 9, 2013 - 10:00am
tags:
Ariad Pharmaceuticals, FDA, non-small cell lung cancer, AP26113
Synergy sees initiating phase 3 program for plecanatide in CIC in Q4
Yahoo/Fly on the Wall
Friday, August 9, 2013 - 9:46am
tags:
Synergy Pharmaceuticals, plecanatide, chronic idiopathic constipation
Amarin's Q2 Shows Large Losses, Prescription Progress
Seeking Alpha
Friday, August 9, 2013 - 9:45am
tags:
Amarin, earnings
Novo Nordisk Getting Its Trial By Fire
Investopedia
Friday, August 9, 2013 - 9:44am
tags:
earnings, Novo Nordisk, diabetes, Teva, Eli Lilly, Sanofi
Sun Pharmaceutical Profit Surges Before Pfizer Settlement Charge
Bloomberg
Friday, August 9, 2013 - 9:41am
tags:
Sun Pharma, earnings, Pfizer
Zogenix Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Friday, August 9, 2013 - 9:40am
tags:
earnings, Zogenix
Pharma professionals feeling angst, but see a few rays of hope
Fierce Pharma
Thursday, August 8, 2013 - 6:56pm
tags:
Big Pharma, patent cliff

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.